Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Incyte Corp (INCY)

Incyte Corp (INCY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,601,136
  • Shares Outstanding, K 222,475
  • Annual Sales, $ 2,986 M
  • Annual Income, $ 948,580 K
  • 60-Month Beta 0.73
  • Price/Sales 5.60
  • Price/Cash Flow 35.16
  • Price/Book 4.40
Trade INCY with:

Options Overview Details

View History
  • Implied Volatility 30.74% ( +5.58%)
  • Historical Volatility 18.72%
  • IV Percentile 29%
  • IV Rank 33.54%
  • IV High 47.34% on 03/01/22
  • IV Low 22.36% on 12/16/22
  • Put/Call Vol Ratio 2.16
  • Today's Volume 1,666
  • Volume Avg (30-Day) 731
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 15,372
  • Open Int (30-Day) 19,743

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.45
  • Number of Estimates 8
  • High Estimate 0.58
  • Low Estimate 0.27
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +742.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.28 +7.77%
on 01/11/23
86.29 -2.24%
on 01/26/23
+3.49 (+4.32%)
since 01/06/23
3-Month
75.46 +11.79%
on 11/11/22
86.29 -2.24%
on 01/26/23
+7.06 (+9.13%)
since 11/04/22
52-Week
65.07 +29.64%
on 06/14/22
86.29 -2.24%
on 01/26/23
+11.67 (+16.05%)
since 02/04/22

Most Recent Stories

More News
Biotech Stocks' Q4 Earnings Due on Feb 7: VRTX, INCY and EXEL

Let us take a look at what is in store for some of the biotech stocks VRTX, INCY and EXEL, which are scheduled to report on Feb 7.

JNJ : 163.36 (-0.76%)
GILD : 86.36 (+2.20%)
VRTX : 304.87 (+1.28%)
INCY : 84.36 (+0.90%)
EXEL : 17.27 (-1.60%)
2 Steady Stocks to Buy in a Recession

Both companies are performing better than the broader market over the past year.

ABBV : 145.02 (-0.12%)
INCY : 84.36 (+0.90%)
3 Reasons Why Growth Investors Shouldn't Overlook Incyte (INCY)

Incyte (INCY) could produce exceptional returns because of its solid growth attributes.

INCY : 84.36 (+0.90%)
Incyte (INCY) to Report Q4 Earnings: What's in the Cards?

Incyte's (INCY) fourth-quarter 2022 earnings are likely to have gained from higher Jakafi sales and incremental sales from newly approved drugs.

NVS : 85.47 (-0.44%)
NVO : 138.07 (+0.94%)
GILD : 86.36 (+2.20%)
INCY : 84.36 (+0.90%)
Incyte (INCY) is a Great Momentum Stock: Should You Buy?

Does Incyte (INCY) have what it takes to be a top stock pick for momentum investors? Let's find out.

INCY : 84.36 (+0.90%)
Incyte to Present at Upcoming Investor Conference

Incyte (Nasdaq:INCY) announced today that it will present at the Guggenheim Healthcare Talks l Oncology Day on Wednesday, February 8, 2023 at 1:35 p.m. (EST) in New York.

INCY : 84.36 (+0.90%)
Incyte (INCY) Up 7% in a Year: Will the Momentum Continue?

Incyte (INCY) outperforms the biotech industry in the past year and the momentum is anticipated to continue in 2023 as well.

NVS : 85.47 (-0.44%)
LLY : 337.66 (-0.42%)
INCY : 84.36 (+0.90%)
SNDX : 26.53 (-5.11%)
Incyte to Report Fourth Quarter and Year-End 2022 Financial Results

Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2022 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023.

INCY : 84.36 (+0.90%)
LGND vs. INCY: Which Stock Should Value Investors Buy Now?

LGND vs. INCY: Which Stock Is the Better Value Option?

LGND : 71.68 (+0.32%)
INCY : 84.36 (+0.90%)
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond

These two biotechs are flying high right now.

CRSP : 55.51 (+0.43%)
NVS : 85.47 (-0.44%)
ARKG : 34.56 (-2.04%)
VRTX : 304.87 (+1.28%)
INCY : 84.36 (+0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2...

See More

Key Turning Points

3rd Resistance Point 87.33
2nd Resistance Point 86.09
1st Resistance Point 85.22
Last Price 84.36
1st Support Level 83.11
2nd Support Level 81.87
3rd Support Level 81.00

See More

52-Week High 86.29
Last Price 84.36
Fibonacci 61.8% 78.18
Fibonacci 50% 75.68
Fibonacci 38.2% 73.18
52-Week Low 65.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar